Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person The extreme N-terminus of BRCA2, involving amino acid residu...

Class:IdSummation:9709618
_displayNameThe extreme N-terminus of BRCA2, involving amino acid residu...
_timestamp2020-12-16 18:25:37
created[InstanceEdit:9709619] Orlic-Milacic, Marija, 2020-12-16
textThe extreme N-terminus of BRCA2, involving amino acid residues 10-40, is necessary and sufficient for PALB2 binding (Xia et al. 2006). Several germline BRCA2 missense mutations identified in breast cancer patients map to this region and impair the ability of BRCA2 recombinant constructs that include the first 60 amino acids of BRCA2 to bind to PALB2:
BRCA2 G25R (severely diminished binding to PALB2, Xia et al. 2006)
BRCA2 W31R (complete loss of PALB2 binding, Xia et al. 2006)
BRCA2 W31C (complete loss of PALB2 binding, Xia et al. 2006)
(summation)[FailedReaction:9709601] Defective recruitment of BRCA2 and RAD51 due to loss of BRCA2 function in PALB2 binding [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by The extreme N-terminus of BRCA2, involving amino acid residu... (9709618)